electroCore Expands Intellectual Property Portfolio
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2025
0mins
Source: Globenewswire
Patent Issuance: electroCore, Inc. has received five new patents from the USPTO related to bioelectronic medicine, including methods for treating medical conditions through electrical stimulation and devices for non-invasive nerve stimulation.
Company Overview: electroCore focuses on commercializing non-invasive vagus nerve stimulation (nVNS) technologies aimed at improving health and wellness, with applications in managing various medical conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
